Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 9/2008

01.09.2008 | Otology

Impaired CD4+CD25+ regulatory T cell activity in the peripheral blood of patients with autoimmune sensorineural hearing loss

verfasst von: Ming Xia, Han Bing Zhang, Fang Liu, Hai Ying Yin, An Ting Xu

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

CD4+CD25+ regulatory T cells exert an immune regulatory function and thus play an important role in the control of self-reactivity in the pathogenesis of autoimmune inflammatory conditions. The aim of the study presented here is to perform a quantitative and functional analyses of these cells in patients with autoimmune sensorineural hearing loss (ASNHL). T cell subsets (CD4+CD25+, CD4+CD25high, CD4+, and CD8+) from the peripheral blood of 17 patients with ASNHL, 16 patients with noise induced hearing loss (NHL), and 100 normal controls were analyzed by flow cytometry. The CD4/CD8 ratio was also analyzed. In addition, the suppressive capability of CD4+CD25+ T cells was tested in vitro by measuring their ability to suppress the proliferation and IFN-γ secretion of CD4+CD25 T cells. No significant difference was found in the T cell subsets of ASNHL patients compared to normal controls or NHL patients, except that the proportion of CD4+ T cells was elevated in ASNHL patients. However, we did observe defective regulatory function of CD4+CD25+T cells in patients with ASNHL. Our data supported the idea that CD4+CD25+ regulatory T cells played an immunosuppressive function in the periphery. The impaired suppressive activity of these cells may be an important factor in the pathogenesis of ASNHL.
Literatur
1.
Zurück zum Zitat McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585–589PubMed McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585–589PubMed
2.
Zurück zum Zitat Solares CA, Hughes GB, Tuohy VK (2003) Autoimmune sensorineural hearing loss: an immunologic perspective. J Neuroimmunol 138:1–7PubMedCrossRef Solares CA, Hughes GB, Tuohy VK (2003) Autoimmune sensorineural hearing loss: an immunologic perspective. J Neuroimmunol 138:1–7PubMedCrossRef
3.
Zurück zum Zitat McCabe BF, McCormick KJ (1984) Tests for autoimmune disease in otology. Am J Otol 5:447–449PubMed McCabe BF, McCormick KJ (1984) Tests for autoimmune disease in otology. Am J Otol 5:447–449PubMed
4.
Zurück zum Zitat Lorenz RR, Solares CA, Williams P, Sikora J, Pelfrey CM, Hughes GB, Tuohy VK (2002) Interferon-gamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss. J Neuroimmunol 130:173–178PubMedCrossRef Lorenz RR, Solares CA, Williams P, Sikora J, Pelfrey CM, Hughes GB, Tuohy VK (2002) Interferon-gamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss. J Neuroimmunol 130:173–178PubMedCrossRef
5.
Zurück zum Zitat Yamanobe S, Harris JP (1992) Spontaneous remission in experimental autoimmune labyrinthitis. Ann Otol Rhinol Laryngol 101:1007–1014PubMed Yamanobe S, Harris JP (1992) Spontaneous remission in experimental autoimmune labyrinthitis. Ann Otol Rhinol Laryngol 101:1007–1014PubMed
6.
Zurück zum Zitat Gloddek B, Gloddek J, Arnold W (1999) A rat T-cell line that mediates autoimmune disease of the inner ear in the Lewis rat. ORL J Otorhinolaryngol Relat Spec 61:181–187PubMed Gloddek B, Gloddek J, Arnold W (1999) A rat T-cell line that mediates autoimmune disease of the inner ear in the Lewis rat. ORL J Otorhinolaryngol Relat Spec 61:181–187PubMed
7.
Zurück zum Zitat Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S et al (1993) Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 151:5770–5776PubMed Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S et al (1993) Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 151:5770–5776PubMed
8.
Zurück zum Zitat Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T-cell recognition of an immunodominant myelin basic protein epitope inmultiple sclerosis. Nature 346:183–187PubMedCrossRef Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T-cell recognition of an immunodominant myelin basic protein epitope inmultiple sclerosis. Nature 346:183–187PubMedCrossRef
9.
Zurück zum Zitat Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164PubMed Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164PubMed
10.
Zurück zum Zitat O’Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10:801–805PubMedCrossRef O’Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10:801–805PubMedCrossRef
11.
Zurück zum Zitat Li Z, Mahesh SP, Kim BJ, Buggage RR, Nussenblatt RB (2003) Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun 21:83–92PubMedCrossRef Li Z, Mahesh SP, Kim BJ, Buggage RR, Nussenblatt RB (2003) Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun 21:83–92PubMedCrossRef
12.
Zurück zum Zitat Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25+ high regulatory cells in human peripheral blood. J Immunol 167:1245–1253PubMed Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25+ high regulatory cells in human peripheral blood. J Immunol 167:1245–1253PubMed
13.
Zurück zum Zitat Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001) Identification and functional characterization of human CD4 (+)CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294PubMedCrossRef Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001) Identification and functional characterization of human CD4 (+)CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294PubMedCrossRef
14.
Zurück zum Zitat Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971–979PubMedCrossRef Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971–979PubMedCrossRef
15.
Zurück zum Zitat Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C (2003) Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215–223PubMedCrossRef Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C (2003) Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215–223PubMedCrossRef
16.
Zurück zum Zitat Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K et al (2002) Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131–140PubMed Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K et al (2002) Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131–140PubMed
17.
Zurück zum Zitat Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ et al (2003) Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 290:1875–1883PubMedCrossRef Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ et al (2003) Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 290:1875–1883PubMedCrossRef
18.
Zurück zum Zitat Baek MJ, Park HM, Johnson JM, Altuntas CZ, Jane-Wit D, Jaini R et al (2006) Increased frequencies of cochlin-specific t cells in patients with autoimmune sensorineural hearing loss. J Immunol 177:4203–4210PubMed Baek MJ, Park HM, Johnson JM, Altuntas CZ, Jane-Wit D, Jaini R et al (2006) Increased frequencies of cochlin-specific t cells in patients with autoimmune sensorineural hearing loss. J Immunol 177:4203–4210PubMed
19.
Zurück zum Zitat Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmström V (2004) CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 6:335–346CrossRef Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmström V (2004) CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 6:335–346CrossRef
20.
Zurück zum Zitat Jiang S, Camara N, Lombardi G, Lechler RI (2003) Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex-vivo. Blood 102:2180–2186PubMedCrossRef Jiang S, Camara N, Lombardi G, Lechler RI (2003) Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex-vivo. Blood 102:2180–2186PubMedCrossRef
21.
Zurück zum Zitat Sakaguchi S (2005) Naturally arising FoxP3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:343–352CrossRef Sakaguchi S (2005) Naturally arising FoxP3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:343–352CrossRef
22.
Zurück zum Zitat Shevach EM (2004) Regulatory/suppressor T cells in health and disease. Arthritis Rheum 50:2721–2724PubMedCrossRef Shevach EM (2004) Regulatory/suppressor T cells in health and disease. Arthritis Rheum 50:2721–2724PubMedCrossRef
23.
Zurück zum Zitat Kusakari C, Hozawa K, Koike S, Kyogoku M, Takasaka T (1992) MRL/Mp-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss. Ann Otol Rhinol Laryngol Suppl 157:82–86PubMed Kusakari C, Hozawa K, Koike S, Kyogoku M, Takasaka T (1992) MRL/Mp-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss. Ann Otol Rhinol Laryngol Suppl 157:82–86PubMed
24.
Zurück zum Zitat Monk CR, Spachidou M, Rovis F, Leung E, Botto M, Lechler RI et al (2005) MRL/Mp CD4+,CD25-T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 52:1180–1184PubMedCrossRef Monk CR, Spachidou M, Rovis F, Leung E, Botto M, Lechler RI et al (2005) MRL/Mp CD4+,CD25-T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 52:1180–1184PubMedCrossRef
25.
Zurück zum Zitat Yang M, Zheng J, Yang Q, Yao H, Chen Y, Tan H et al (2004) Frequency-specific association of antibodies against heat shock proteins 0 and 70 with noise-induced hearing loss in Chinese workers. Cell Stress Chaperones 9:207–213PubMedCrossRef Yang M, Zheng J, Yang Q, Yao H, Chen Y, Tan H et al (2004) Frequency-specific association of antibodies against heat shock proteins 0 and 70 with noise-induced hearing loss in Chinese workers. Cell Stress Chaperones 9:207–213PubMedCrossRef
Metadaten
Titel
Impaired CD4+CD25+ regulatory T cell activity in the peripheral blood of patients with autoimmune sensorineural hearing loss
verfasst von
Ming Xia
Han Bing Zhang
Fang Liu
Hai Ying Yin
An Ting Xu
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 9/2008
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-007-0565-9

Weitere Artikel der Ausgabe 9/2008

European Archives of Oto-Rhino-Laryngology 9/2008 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.